Dolby Laboratories (NYSE:DLB) Announces Earnings Results

Dolby Laboratories (NYSE:DLB) posted its quarterly earnings results on Tuesday. The electronics maker reported $0.99 EPS for the quarter, beating analysts’ consensus estimates of $0.70 by $0.29, FiscalAI reports. The business had revenue of $307.02 million for the quarter, compared to analysts’ expectations of $305.76 million. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The business’s quarterly revenue was up .7% on a year-over-year basis. During the same period last year, the firm earned $0.61 earnings per share. Dolby Laboratories updated its FY 2026 guidance to 4.190-4.340 EPS and its Q1 2026 guidance to 0.790-0.940 EPS.

Dolby Laboratories Stock Up 0.9%

Shares of DLB opened at $65.13 on Wednesday. The business has a fifty day moving average of $68.93 and a 200 day moving average of $72.51. The company has a market cap of $6.24 billion, a PE ratio of 23.86 and a beta of 0.97. Dolby Laboratories has a 52-week low of $64.02 and a 52-week high of $89.66.

Dolby Laboratories Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd will be issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 2.2%. The ex-dividend date is Tuesday, December 2nd. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s payout ratio is currently 48.35%.

Analyst Upgrades and Downgrades

A number of research firms recently commented on DLB. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Thursday, November 13th. Barrington Research reduced their price objective on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a research report on Wednesday. Tigress Financial boosted their target price on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a report on Friday, August 15th. Rosenblatt Securities set a $85.00 target price on shares of Dolby Laboratories and gave the company a “buy” rating in a research note on Wednesday. Finally, Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, August 30th. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Dolby Laboratories has an average rating of “Moderate Buy” and an average price target of $92.00.

Insiders Place Their Bets

In related news, SVP Shriram Revankar sold 7,000 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the sale, the senior vice president directly owned 70,435 shares of the company’s stock, valued at approximately $5,276,990.20. This trade represents a 9.04% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kevin J. Yeaman sold 25,000 shares of the stock in a transaction on Tuesday, October 14th. The stock was sold at an average price of $68.87, for a total value of $1,721,750.00. Following the completion of the sale, the chief executive officer owned 114,725 shares in the company, valued at approximately $7,901,110.75. The trade was a 17.89% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 57,000 shares of company stock worth $4,037,690 in the last quarter. Company insiders own 38.39% of the company’s stock.

Institutional Investors Weigh In On Dolby Laboratories

Large investors have recently added to or reduced their stakes in the stock. AQR Capital Management LLC boosted its position in Dolby Laboratories by 51.8% during the 2nd quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after acquiring an additional 592,282 shares in the last quarter. State Street Corp boosted its holdings in shares of Dolby Laboratories by 8.7% in the 2nd quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after buying an additional 180,072 shares in the last quarter. Goldman Sachs Group Inc. grew its position in shares of Dolby Laboratories by 218.8% in the 1st quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock worth $20,043,000 after buying an additional 171,288 shares during the last quarter. Millennium Management LLC raised its stake in shares of Dolby Laboratories by 349.4% during the 3rd quarter. Millennium Management LLC now owns 217,779 shares of the electronics maker’s stock worth $15,761,000 after acquiring an additional 169,319 shares in the last quarter. Finally, Squarepoint Ops LLC lifted its position in Dolby Laboratories by 37.2% during the third quarter. Squarepoint Ops LLC now owns 516,700 shares of the electronics maker’s stock valued at $37,394,000 after acquiring an additional 140,201 shares during the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.